From meat producer to protein specialist:

Versmold, September 15, 2022 – As of today, with the launch of the third company pillar “The Cultivated B” (TCB), the protein strategy of InFamily Foods Holding GmbH & Co KG is complete. In addition to sausage, ham, and plant-based alternative products, the corporate group is expanding its portfolio from a pure product supplier to a technology partner. The former two sausage and ham producers are poised to become one of the leading international suppliers of protein solutions. Along the way, the InFamily Foods group will continue to focus on conventional animal as well as plant-based proteins. At the same time, the company is turning to alternative cell-based proteins, a key technology for greater efficiency and sustainability in the protein market. 

On a course for growth: InFamily Foods aims to hit its first billion in just three years 

“After the successful merger and integration of Kemper and Reinert three years ago, we have positioned ourselves operationally to compete in a competitive market characterized by pricing pressures, where we will leverage the market conditions to our benefit,” says InFamily Foods Holding partner Dr. Wolfgang Kühnl. “We are not replacing sausage and ham with veggies and Co. Instead, InFamily Foods is following a comprehensive protein strategy,” Kühnl continues. The three independent business divisions The Family Butchers, The Plantly Butchers, and The Cultivated B pursue independent strategies and serve distinct markets with specific sales structures and development potential.  

The forward strategy of the sausage and ham line banks on improved animal welfare standards, new consumer incentives, and sustainability, as well as on opening up new international sales markets. In both the sausage and ham and vegetarian segments, the company is focusing on establishing new strong product lines – such as the recently launched Billie Green brand – and on expanding the white label market for vegetarian products. Beyond its own production activities, the company is now entering a new market segment as a knowledge and technology partner with its third corporate pillar. “With InFamily Foods, we have created an adaptable and flexible platform that allows us to respond to different markets and customer needs. At the same time, we are leveraging synergies and are able to bundle competencies in the area of technology,” explains InFamily Foods Holding partner Hans-Ewald Reinert. “Consolidation in the meat sector was the first important step, further development of the portfolio outside the core sector the second,” Reinert continues. In three years, the group expects its protein strategy to have reorganized the protein market, reaching a sales target of one billion euros.  

Next level: Driving cellular agriculture with TCB 

“Technology was always the driving force behind Kemper’s business activities. Now we are taking technology and food to a whole other level,” says Dr. Wolfgang Kühnl on the launch of the company’s third pillar, The Cultivated B. “We see ourselves as an enabler of the major up-and-coming topic of alternative proteins and are busy establishing a global business from here in Germany,” he continues. Due to the regulatory landscape, the relevant markets are primarily outside the EU.  

“The technologies our international scientific team has developed over the last year and a half have the potential to enable industrial-scale cellular agriculture,” says Raphael Heiner, CEO of TCB. “The Cultivated B’s technology will serve as a springboard for governmental organizations, large-scale food industry enterprises, and pharmaceutical companies to rethink their protein products as more sustainable solutions,” Heiner continues. TCB’s solutions in technology and production have relevance for the entire cellular agriculture value chain, optimizing the production of alternative proteins for the food, pharmaceutical, and cosmetics industries. To name but a few activities here, TCB manufactures and sells bioreactors as well as offers licenses for cultured meats. The company currently runs a research and development center in Germany and a production facility in Canada. TCB plans for its sales to reach the one-billion-euro mark in ten years.  

The global protein market is growing in the wake of greater prosperity. With the new InFamily Foods group protein strategy, the company is harnessing all available opportunities to create value chains in the important early starters’ business.

Press Contact:

1. Deekeling Arndt/Amo 
2. Phone: +49 174 335 81 15 
3. Email: press(at)infamily-foods.com
4. Website: www.infamily-foods.com